Skip to content

Melanoma and HRT

A recent report from Koomen and colleagues in the Annals of Oncology [1] has reopened the discussion on the association between the development of cutaneous melanoma (CM) and hormones.  The paper reports on a case–control study conducted in the Netherlands using two databases: PHARMO, a pharmacy database recording all prescriptions on an individual basis, and… Read More

HRT and sarcopenia

A recently published study is part of a larger research project on postmenopausal sarcopenia and the effects of hormone replacement therapy (HRT) and physical activity [1]. Fifteen 54–62-year-old monozygotic female twin pairs, where one twin in each pair was receiving HRT and the other twin was not, were recruited from the Finnish Twin Cohort. This… Read More

Approach to the patient with menopausal symptoms

Using a case history of a patient with classical menopausal symptoms, Martin and Manson have recently reviewed in brief the recent data and controversies over hormone replacement therapy (HRT) and discussed hormonal regimens (oral, transdermal) and dosage, duration of therapy and alternative treatment options [1]. The main motif of the article is safety, namely, how… Read More

Postmenopausal hormone use and breast cancer risk

In a recently published investigation [1], Calle and colleagues selected a large cohort of postmenopausal US women (n = 67,754) from the 97,786 female participants of the prospective study Cancer Prevention Study II Nutrition Cohort. This cohort was established in 1982 by the American Cancer Society. Women aged 50–74 years were mailed self-administered questionnaires from… Read More

Tibolone increases the risk of recurrence in breast cancer patients, while relieving vasomotor symptoms and preventing bone loss

Kenemans and colleagues have recently reported the effects of tibolone, as compared to placebo, on risk of recurrence in breast cancer patients with climacteric complaints [1]. During 2002–2004, in the prospective multicenter LIBERATE trial, as many as 3148 women, after surgery for confirmed breast cancer and with vasomotor symptoms, were randomized to receive either tibolone… Read More

Weight loss and urinary incontinence

Obesity is an established and modifiable risk factor for urinary incontinence, but conclusive evidence for a beneficial effect of weight loss on urinary incontinence is lacking. In a recently published study by Subak and colleagues [1], 338 overweight and obese women, with a mean age of 53 ± 11 years, and with at least ten… Read More

International Menopause Society

Install International Menopause Society - DEV

Install this application on your home screen for quick and easy access when you’re on the go.

Just tap then “Add to Home Screen”